Where does Pacira Pharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Pacira Pharmaceuticals, Inc. ranks #6,264 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Pacira Pharmaceuticals, Inc. hold?

Pacira Pharmaceuticals, Inc. holds 54 US utility patents granted between 2015 and 2025, spanning 8 technology areas.

What is Pacira Pharmaceuticals, Inc.'s Innovation Score?

Pacira Pharmaceuticals, Inc. has an Innovation Score of 52.2 out of 100 (top 10% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Pacira Pharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

Pacira Pharmaceuticals, Inc.'s recent grant velocity is +93% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Pacira Pharmaceuticals, Inc.'s patents?

Pacira Pharmaceuticals, Inc.'s patents average 29.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Pacira Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Pacira Pharmaceuticals, Inc.

Q: What technology areas does Pacira Pharmaceuticals, Inc. focus on?

Pacira Pharmaceuticals, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 54 patents. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 54 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Pacira ranks #6,264 of 49,997 tracked US assignees by granted-patent volume, with 54 patents across 8 technology areas.

#6,264
of 49,997 US assignees by volume: Top 10%
by Innovation Score (52.2/100): 29.1
avg claims per patent: +93%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6264 · US Corporation #6,264 · 54 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 54 grants
UPPER-Q #6,264/49,997
PHOTO-FINISH Outotec Oyj
CPC-NARROW A61K · 8 areas
INNOV-PAR 52.2/100
CLAIMS-DENSE 29.1 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +93% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Outotec Oyj (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Zazzle · near

52
Calix · near

52
Pacira Pharmaceuticals · this assignee

52
Shinshu University · near

52
Sinox · near

52
3D Lighting… · lowest

7

What this shows Pacira's Innovation Score is 52.2/100 (top 10% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Pacira's grants concentrate

Pacira Pharmaceuticals, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2017 (8 grants) versus a trough of 1 in 2019. By volume, Pacira sits between Outotec Oyj and Research Cooperation Foundation OF Yeungnam University.

Pacira's three-year grant acceleration

Pacira Pharmaceuticals, Inc. shows 20 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Outotec Oyj

54
Poly-clip System…

54
Polytronics Techn…

54
Progress Profiles…

54
Phase Sensitive I…

54
Qwest Communicati…

54
REE Automotive

54
Research Cooperat…

54
Pacira Pharmaceut… ◀

54

What this shows Pacira holds 54 patents at rank #6,266, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Pacira

By rank, the assignees closest to #6,266 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Pacira's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Pacira, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (52 here).

Calix, Inc. 52 Shinshu University 52 Sinox Company Ltd. 52 Zazzle Inc. 52

Similar claim depth

Nearest assignees by average claims per patent (29.1 here).

Qualcomm Incorporated 29.1 avg Centripetal Networks, LLC 29.0 avg Peregrine Semiconductor Corporation 28.9 avg Prothena Biosciences Limited 28.9 avg

Pacira's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

52 Top 10% higher than 90% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Pacira Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	3.7%
2017	8	14.8%
2018	4	7.4%
2019	1	1.9%
2020	5	9.3%
2021	4	7.4%
2022	6	11.1%
2023	6	11.1%
2024	8	14.8%
2025partial year	10	18.5%

Which technologies does Pacira Pharmaceuticals, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 54

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 34

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 20

B01D - Separation 20

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 9

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 8

A61B - DIAGNOSIS; SURGERY; Identification 3

B65G - Transport OR Storage Devices, e.g. Conveyors FOR Loading OR Tipping, Shop Conveyor Systems OR Pneumatic Tube Conveyors 1

Top 8 of 8 technology areas

Where it ranks

Overall rank by patents

#6,264

of 49,997 tracked assignees

Innovation Score

52.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Pacira Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

Pacira Pharmaceuticals, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #6,264 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Pacira Pharmaceuticals, Inc. against Outotec Oyj, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 52.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.